Fatigue, Hypoxia, Anemia
Fatigue: Evaluation, Treatment Impact
Cancer-Related Fatigue: Guidelines for Evaluation and Management
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition
Hypoxia
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Tumor Hypoxia: Definitions and Current Clinical, biologic, and Molecular Aspects
Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response
Treatment of Anemia
Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis pdf
A Retrospective Review of Blood Transfusions in Cancer Patients with Anemia
The Evolving Role of Epoetin Alfa in Cancer Therapy
Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective sub analysis of two large, community-based trials
Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy
Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer